Company Revenue

The company set a new revenue record in 2Q21 thanks in large part to the synergistic impact of its ExcelsiusGPS...

In 2Q21 the company made impressive gains in sports medicine and extremities but has yet to find a path to...

The company bounced back in 2Q21 from the pandemic low point but, as expected, its orthopedic business remains well off...

In 2Q21, the company drove incremental gains over 2019 as markets continue to recover. DJO expects to be a $1...

Although the company finished 2Q21 ahead of its 2019 performance, its knee franchise was double digits for that same comparison...

While the company's sales increased in FY 1Q21, it issued a safety warning regarding potential side effects of its new...

The company's expanding presence in the cervical spine market helped it grow slightly in 2Q21 compared to 2Q19....

The company maintained momentum in 2Q21, growing +19% compared to 2Q19 driven by Mako and upper extremity sales....

While the company grew more than +50% compared to 2Q20, the recovery of key segments like knee replacement and spine...

The company said its established markets are nearing pre-pandemic sales levels, with ongoing monthly improvement....